Affinity Asset Advisors’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-25,000
Closed -$1.28M 117
2024
Q4
$1.28M Sell
25,000
-35,000
-58% -$1.72M 0.17% 65
2024
Q3
$2.47M Sell
60,000
-140,000
-70% -$6.72M 0.34% 62
2024
Q2
$9.63M Buy
200,000
+25,000
+14% +$1.11M 1.11% 27
2024
Q1
$8.4M Buy
175,000
+155,000
+775% +$8.28M 1.04% 30
2023
Q4
$1.3M Buy
+20,000
New +$1.2M 0.24% 65
2023
Q2
Sell
-20,000
Closed -$1.23M 91
2023
Q1
$1.23M Sell
20,000
-70,000
-78% -$4.2M 0.41% 52
2022
Q4
$5.72M Sell
90,000
-30,000
-25% -$2.18M 2.24% 15
2022
Q3
$8.72M Sell
120,000
-102,173
-46% -$7.61M 2.43% 12
2022
Q2
$15.1M Buy
222,173
+2,173
+1% +$156K 6.37% 4
2022
Q1
$19.9M Buy
220,000
+95,000
+76% +$7.78M 3.19% 2
2021
Q4
$11.4M Sell
125,000
-10,000
-7% -$857K 4.14% 5
2021
Q3
$10.9M Buy
135,000
+50,000
+59% +$4.2M 2.77% 6
2021
Q2
$7.93M Buy
85,000
+35,000
+70% +$3.39M 2.84% 9
2021
Q1
$5.35M Buy
50,000
+40,000
+400% +$4.15M 1.82% 14
2020
Q4
$873K Buy
+10,000
New +$706K 0.46% 45

Other funds holding NARI

Affinity Asset Advisors's NARI Position: Q1 2025 in Review

Affinity Asset Advisors sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 25,000 shares — an estimated $1.28M sold.

Affinity Asset Advisors first reported a position in NARI in Q4 2020 and held it in 15 quarters. The position peaked at $19.9M in Q1 2022. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Affinity Asset Advisors reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Affinity Asset Advisors sold 25,000 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $1.28M.
  • Affinity Asset Advisors first reported a position in Inari Medical, Inc. Common Stock in Q4 2020 and held it in 15 quarters.
  • Affinity Asset Advisors's Inari Medical, Inc. Common Stock position peaked at $19.9M in Q1 2022.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Affinity Asset Advisors's 13F filing for Q1 2025, filed 14 May 2025.